Finance

Beta
Lists
4004:TADAWUL
Dallah Healthcare Company SJSC
SAR 105.30
+0.67%
(+0.70) 1D
Jun 7, 3:17:39 PM GMT+3  ·   SAR
All symbols
SymbolPriceChange% Change
Generating top insights for 4004...
Open
SAR 104.00
High
SAR 105.70
Low
SAR 102.90
Mkt. cap
10.70B
Avg. vol.
129.08K
Volume
79.52K
Dividend
1.90%
Quarterly dividend
SAR 0.50
Ex-dividend date
May 18, 2026
P/E ratio
22.99
52-wk high
SAR 157.30
52-wk low
SAR 90.00
EPS
SAR 4.58
Shares outstanding
48.33M
Open
SAR 104.00
High
SAR 105.70
Low
SAR 102.90
Mkt. cap
10.70B
Avg. vol.
129.08K
Volume
79.52K
Dividend
1.90%
Quarterly dividend
SAR 0.50
Ex-dividend date
May 18, 2026
P/E ratio
22.99
52-wk high
SAR 157.30
52-wk low
SAR 90.00
EPS
SAR 4.58
Shares outstanding
48.33M
News stories
From sources across the web
About Dallah Healthcare Company SJSC
CEO-
Employees-
Founded1987
Headquarters-
SectorHealth care provider
Previous reportsAll values in SAR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SAR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.06B
1.06B
1.11B
1.01B
Cost of goods sold
686.55M
680.65M
775.39M
679.18M
Cost of revenue
686.55M
680.65M
775.39M
679.18M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
212.75M
221.32M
171.87M
212.19M
Operating expense
220.89M
223.03M
231.12M
213.73M
Total operating expenses
907.44M
903.67M
1.01B
892.91M
Operating income
154.99M
157.59M
103.93M
120.36M
Other non operating income
-
-
-
-
EBT including unusual items
120.96M
149.86M
117.91M
87.98M
EBT excluding unusual items
120.96M
149.86M
66.90M
87.98M
Income tax expense
-6.70M
5.18M
6.48M
2.70M
Effective tax rate
-5.54%
3.46%
5.49%
3.07%
Other operating expenses
-7.28M
-9.08M
47.97M
-10.63M
Net income
124.26M
141.90M
116.55M
84.52M
Net profit margin
11.70%
13.37%
10.50%
8.34%
Earnings per share
1.23
1.40
1.10
0.84
Interest and investment income
-
-
12.09K
-
Interest expense
-46.34M
-17.83M
-57.23M
-43.27M
Net interest expenses
-46.34M
-17.83M
-57.22M
-43.27M
Depreciation and amortization charges
-
-
-
-
EBITDA
199.41M
202.44M
146.40M
171.79M
Gain or loss from assets sale
-
514.99K
-438.56K
582.96K
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more